EpiVax Receives $600,000 Grant to develop treatment for Diabetes from National...
Business Wire via Yahoo! Finance: 1 views since Tuesday, July 8, 2008 at 08:45 AM
PROVIDENCE, R.I.----EpiVax, Inc, a leader in the field of computational immunology, announced today that it has received a grant from the National Institute of Diabetes and Digestive and Kidney Diseases , a division of the National Institutes of Health , to develop ?Epi-13?, a novel therapeutic for the prevention and treatment of Type 1 diabetes, a devastating and chronic autoimmune disease ...

Published in: Institutes